Research and Markets: CF101 (Dry Eye Syndrome) - Analysis and Forecasts to 2022

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/n3dzxx/cf101_dry_eye) has announced the addition of GlobalData's new report "CF101 (Dry Eye Syndrome) - Analysis and Forecasts to 2022" to their offering.

“CF101 (Dry Eye Syndrome) - Analysis and Forecasts to 2022”

The pharmaceuticals report CF101 (Dry Eye Syndrome) - Analysis and Forecasts to 2022 provides CF101 sales forecasts for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2022). The report also includes information on Dry Eye Syndrome.

This report is built using data and information sourced from Our proprietary databases, primary and secondary research using Company's corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by Our team of industry experts.

Scope

- Therapy area profile including patient population for the US and EU5.

- Analysis and review of CF101 including sales data

- Qualitative and quantitative assessment of market space

- Analysis of the trends, drivers and restraints shaping and defining the markets

- In-depth analysis of CF101 Liquid including efficacy, safety, pricing, competition and other details which influence its sales potential

- Detailed sales forecast for 2013-2022 for CF101 in the US and EU5

Reasons to Buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return

- Stay ahead of competition by understanding the changing competitive landscape

- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential

- Make more informed business decisions from insightful and in-depth analysis of the drug's performance

- Examine the historical sales performance of a drug in six major markets

- Obtain sales forecast for currently marketed/pipeline drug for 2013-2022 for all six major markets

Key Topics Covered

1 List of Tables and Figures

2 Introduction

2.1 Dry Eye Syndrome Disease

2.2 Dry Eye Syndrome Market

2.3 Epidemiology

2.4 The Main Recognized Risk Factors

2.5 GlobalData Report Guidance

3 Dry Eye Syndrome: Market Characterization

3.1 Dry Eye Syndrome Market

3.2 Dry Eye Syndrome Market Forecasts and CAGR

3.3 Drivers and Barriers of Dry Eye Syndrome Therapeutics Market

4 Classification of Dry Eye Syndrome

4.1 Classification based on Severity Grading Scheme

4.2 Classification based on Signs and Symptoms

5 Treatment for Dry Eye Syndrome

5.1 Pharmacological Treatment

5.2 Surgical Interventions

5.3 Non Surgical Interventions

6 CF101

6.1 Introduction

6.2 Mechanism of Action

6.3 Clinical Studies

6.4 Factors Affecting Sales of CF101

6.5 Drug Evaluation

6.6 Sales Forecasts

7 Appendix

7.1 Market Definitions

7.2 List of Abbreviations

7.3 Research Methodology

7.4 Drug Sales Estimates Model

7.5 Contact Us

7.6 Disclaimer

7.7 Sources

For more information visit http://www.researchandmarkets.com/research/n3dzxx/cf101_dry_eye

Source: GlobalData